The Transfusion Evidence Alert email arrived in
my in-box today. There was quite a bit to take in; I’ll just reproduce the articles
I felt were most relevant to me…
The Effect of Tranexamic Acid on Functional Outcomes: An Exploratory Analysis of the CRASH-2 Randomized Controlled Trial
Nishijima, D. K., Kuppermann, N., et al. Annals of emergency medicine 2019.
Nishijima, D. K., Kuppermann, N., et al. Annals of emergency medicine 2019.
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura
Scully, M., Cataland, S. R., et al. The New England journal of Medicine 2019.
Scully, M., Cataland, S. R., et al. The New England journal of Medicine 2019.
Additional
filtering of blood from a cell salvage device is not likely to show
important additional benefits in outcome in cardiac surgery
de Vries, A. J., Vermeijden, W. J., et al. Transfusion 2019
Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic reviewde Vries, A. J., Vermeijden, W. J., et al. Transfusion 2019
Franchini, M., Forni, G. L., et all. Trasfusione del sangue 2019.
No comments:
Post a Comment